VoyForums
[ Show ]
Support VoyForums
[ Shrink ]
VoyForums Announcement: Programming and providing support for this service has been a labor of love since 1997. We are one of the few services online who values our users' privacy, and have never sold your information. We have even fought hard to defend your privacy in legal cases; however, we've done it with almost no financial support -- paying out of pocket to continue providing the service. Due to the issues imposed on us by advertisers, we also stopped hosting most ads on the forums many years ago. We hope you appreciate our efforts.

Show your support by donating any amount. (Note: We are still technically a for-profit company, so your contribution is not tax-deductible.) PayPal Acct: Feedback:

Donate to VoyForums (PayPal):

[ Login ] [ Contact Forum Admin ] [ Main index ] [ Post a new message ] [ Search | Check update time | Archives: [1], 2, 3, 4 ]

[ Next Thread | Previous Thread | Next Message | Previous Message ]

Date Posted: 22:29:15 12/17/05 Sat
Author: Busted
Subject: Stock scam: HMHB

Holmes Herbs, Inc. (HMHB) Poised for Growth in $70.0 Billion Industry.

Ticker: HMHB.OTC

I/O : 12,000,000

Approx. Float: 1,000,000

Current Price: 5.05

Why we Like this Stock

In the first months of this year, Holmes Herbs Inc. (HMHB OTC:BB) put in
place a Plan to Move the company into the High-Growth business of Contract
Pharmaceutical research and manufacturing. The market is forecast to grow to
$36 Billion by 2010. Worldwide, the outsourced R&D market is expected to
grow to $70.0 Billion annually within 5 years.

Large Pharmaceutical companies have increasingly turned outside their own
organizations for research and manufacturing needs and HMHB has positioned
itself to capitalize on this growing trend

The Trend, according to a new Report from Goldman Sachs, is expected to
accelerate in the foreseeable future and has enjoyed a steady growth rate
The North American market for outsourced pharmaceutical R&D grew from $5.4
Billion to $9.3 Billion Annually between 1997 and 2001. A growth rate of
14.7 percent.

With the recent announcement that HMHB has Acquired a Controlling Interest
in Qualia Clinical Service Inc., HMHB has positioned itself with some of the
Leaders in the Pharmaceutical industry such as Eli Lilly, Merck and Ferring
Pharmaceuticals.

Recent Announcements include:

Dec. 6, 2005--Holmes Herbs, Inc., (OTCBB:HMHB - News), announced today that
it has completed the acquisition and appointed management for Qualia
Clinical Service Inc. ("Qualia").

http://biz.yahoo.com/bw/051206/20051206005041.html?.v=1

Nov. 10, 2005--Holmes Herbs, Inc., (OTCBB:HMHB - News), announced today that
its clinical research partner, Qualia Clinical Research Services Inc.
("Qualia"), recently completed a clinical research contract on behalf of
Merck Pharmaceuticals (MRK:NYSE). The clinical research for Merck
Pharmaceuticals involved a Phase 4 trial on Monteleukast.

http://biz.yahoo.com/bw/051110/20051110005106.html?.v=1

Oct. 11, 2005--Holmes Herbs, Inc., (OTCBB:HMHB - News), announced today that
its clinical research partner, Qualia Clinical Research Services Inc.
("Qualia"), is developing a new clinical research center. This new facility
is designed to conduct Phase I, Phase II and Bioequivalence clinical trials
with state of the art equipment and experienced staff. It is projected to be
completed and operating by February 2006.

http://biz.yahoo.com/bw/051011/115455.html?.v=1

Sept. 29, 2005--Holmes Herbs, Inc., (OTCBB:HMHB - News), announced today
that its clinical research partner, Qualia Clinical Research Services Inc.
("Qualia"), recently completed a clinical research contract on behalf of
Ferring Pharmaceuticals. The clinical research for Ferring Pharmaceuticals
involved a Phase 3 trial on a new formulation to treat enuresis
(bedwetting).

http://biz.yahoo.com/bw/050929/295064.html?.v=1

Sept. 27, 2005--Holmes Herbs, Inc., (OTCBB:HMHB - News), announced today
that its clinical research partner, Qualia Clinical Research Services, Inc.,
("Qualia"), recently completed a clinical research contract on behalf of Eli
Lilly. The clinical research for Eli Lilly involved a Phase 4 trial on
Strattera. Strattera is the first non-stimulant used to treat ADHD
(attention deficit hyperactivity disorder). Eli Lilly (LLY:NYSE) is a
leading innovation-driven worldwide pharmaceutical company.

http://biz.yahoo.com/bw/050927/275055.html?.v=1

For additional information on Holmes Herb, Inc. click here Research Report

Disc|a1mer:
Information within this em4i| c0nta1ns "f0rw4rd |0ok1ng st4t3ments" within
the meaning of Sect10n 27Aof the Secur1ties Act of 1933 and Secti0n_21B of
the Secur1ties_Exchange_Act of 1934. Any statements that express or inv0lve
discussi0ns with respect to pred1cti0ns, expectati0ns, be|iefs, p|ans,
pr0jecti0ns,
objectives, goals, assumptions or future events or performance are not
statements of
historicalfact and may be "f0rw4rd |0ok1ng st4t3ments". "f0rw4rd |0ok1ng
st4t3ments" are based on expectations, estimates and pr0jections at the time
the statements
are made that involve a number of risks and uncertainties which could cause
actual results or events to differ materially from those presently
anticipated. We were paid a sum of three th0us4nd USD to disseminate this
information from non affi1iated 3rd party. f0rw4rd |0ok1ng st4t3ments in
this action may be identified through the use of words such as "projects",
"f0resee", "exp3cts", "wi||", "ant1cipates", "est1mates", "be|ieves",
"understands" or that by statements indicating certain acti0ns "may",
"c0uld", or "might" occur. Risk fact0rs include general economic and
business conditions, the ability to acquire and develop specific projects,
the ability to fund operations and changes in consumerand business
consumption habits and other factors over which the company has little or no
control. The publisher of this news|etter does not represent that the
information contained herein are true and correct.

[ Next Thread | Previous Thread | Next Message | Previous Message ]
[ Contact Forum Admin ]

Forum timezone: GMT-8
VF Version: 3.00b, ConfDB:
Before posting please read our privacy policy.
VoyForums(tm) is a Free Service from Voyager Info-Systems.
Copyright © 1998-2019 Voyager Info-Systems. All Rights Reserved.